SNORD77

gene
On this page

Also known as U77SNORD77A

Summary

SNORD77 (small nucleolar RNA, C/D box 77, HGNC:32737) is a gene on chromosome 1q25.1.

Predicted to be involved in RNA processing. Predicted to be located in nucleolus.

Source: NCBI Gene 692197 — RefSeq curated summary.

At a glance

  • GWAS associations: 3

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:32737
Approved symbolSNORD77
Namesmall nucleolar RNA, C/D box 77
Location1q25.1
Locus typeRNA, small nucleolar
StatusApproved
AliasesU77, SNORD77A
Entrez692197
RNAcentralURS000082A21B — snoRNA, 70 nt, 1 organism(s)

Gene structure

Transcript identifiers

Ensembl transcripts: 0

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

None — 0 exons

Expression profiles

Top tissues by expression

0 total, by Bgee expression score (0-100, higher = more expressed):

Regulation

Is transcription factor: no

Cross-species orthologs

0 orthologs

Protein

Protein identifiers

Canonical reviewed UniProt: None (reviewed: )

All UniProt accessions (0):

RefSeq proteins (0): (*=MANE)

Domains & families (InterPro)

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 0 (showing top):

GO Biological Process (0):

GO Molecular Function (0):

GO Cellular Component (0):

Protein interactions and networks

STRING

0 interactions, top by confidence (×1000):

IntAct

0 interactions, top by confidence:

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

0 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance0
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

0 predictions. Top by Δscore:

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000056001 (1:173867389 G>A), RS1000127752 (1:173867669 A>G), RS1000500475 (1:173868214 T>G), RS1000607514 (1:173867847 G>A,C), RS1000640330 (1:173867622 A>C,G), RS1001991899 (1:173867957 T>A,C), RS1002425896 (1:173868021 A>G), RS1002607397 (1:173866052 A>C), RS1002617054 (1:173865916 A>G), RS1003069702 (1:173865815 G>A), RS1004349924 (1:173868048 G>C), RS1004688779 (1:173867221 A>G), RS1004780584 (1:173867379 G>A), RS1008108625 (1:173868240 G>A,C), RS1008511853 (1:173866575 G>A,T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

3 associations (top):

StudyTraitp-value
GCST008870_6Keratinocyte cancer (MTAG)6.000000e-33
GCST008871_59Basal cell carcinoma6.000000e-38
GCST010304_15Cutaneous malignant melanoma7.000000e-12

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0010176keratinocyte carcinoma

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

5 total (human), top 5 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arseniteincreases expression1
potassium chromate(VI)increases expression, affects cotreatment1
epigallocatechin gallateaffects cotreatment, increases expression1
Estradiolincreases expression1
Valproic Aciddecreases methylation1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.